← NRC HEALTH NRC
Market Price
$21.25
Market Cap
$482.51M
P/E Ratio
0.42
Revenue (FY 2025)
↓-4.0% YoY
$137.39M
3-Yr CAGR: -3.2%
Net Income
↓-53.2% YoY
$11.60M
Net Margin: 8.4%
Free Cash Flow
↓-17.9% YoY
$15.74M
FCF Yield: 3.26%
EPS (Diluted)
↑4,707.7% YoY
$50.00
Basic: $50.00
Return on Equity
Efficiency
82.9%
ROA: 57.4%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (NRC)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $109.4M | — | $109.2M | $20.5M | — | $3.36 | — | $26.8M | $22.9M | — |
| FY 2017 | $117.6M | +7.5% | $117.5M | $22.9M | +11.8% | $3.70 | +10.1% | $28.1M | $23.5M | +2.9% |
| FY 2018 | $119.7M | +1.8% | $118.2M | $30.0M | +31.0% | $3.35 | -9.5% | $39.8M | $33.9M | +44.0% |
| FY 2019 | $128.0M | +6.9% | $125.9M | $32.4M | +7.9% | $2.52 | -24.8% | $40.9M | $36.3M | +7.0% |
| FY 2020 | $133.3M | +4.1% | $131.5M | $37.3M | +15.0% | $2.90 | +15.1% | $40.6M | $36.7M | +1.1% |
| FY 2021 | $148.0M | +11.0% | $146.3M | $37.5M | +0.6% | $1.46 | -49.7% | $46.3M | $40.8M | +11.4% |
| FY 2022 | $151.6M | +2.4% | $150.4M | $31.8M | -15.1% | $1.27 | -13.0% | $36.3M | $26.4M | -35.3% |
| FY 2023 | $148.6M | -2.0% | $147.7M | $31.0M | -2.6% | $1.25 | -1.6% | $38.1M | $22.3M | -15.5% |
| FY 2024 | $143.1M | -3.7% | $140.5M | $24.8M | -20.0% | $1.04 | -16.8% | $34.6M | $19.2M | -14.1% |
| FY 2025 | $137.4M | -4.0% | $132.6M | $11.6M | -53.2% | $50.00 | +4,707.7% | $26.4M | $15.7M | -17.9% |
Valuation
Market Price
$21.25
Market Cap
$482.51M
Enterprise Value
$553.39M
P/E Ratio
0.42
P/B Ratio
34.23
FCF Yield
3.26%
Dividend Yield
2.45%
Shares Outstanding
Profitability & Margins
Gross Margin
96.53%
Operating Margin
16.44%
Net Margin
8.44%
Return on Equity (ROE)
82.92%
Return on Assets (ROA)
57.40%
Asset Turnover
6.80x
Revenue 3-Yr CAGR
-3.22%
Financial Health & Liquidity
Current Ratio
6.98
Cash Ratio
1.43
Debt / Equity
5.362
Debt / Assets
3.712
Cash & Equivalents
$4.14M
Total Debt
$75.02M
Book Value / Share
$0.62
Cash Flow Efficiency
Operating Cash Flow
$26.45M
Capital Expenditures (CapEx)
$10.71M
Free Cash Flow
$15.74M
OCF / Revenue
19.25%
FCF / Revenue
11.46%
FCF 3-Yr CAGR
-15.86%
Per Share Metrics
EPS (Diluted)
$50.00
EPS (Basic)
$50.00
Dividends / Share
$0.52
Book Value / Share
$0.62
EPS YoY Growth
4,707.69%
Balance Sheet (FY 2025)
Total Assets
$20.21M
Total Liabilities
$2.90M
Stockholders' Equity
$13.99M
Current Assets
$20.21M
Current Liabilities
$2.90M